Poly Medicure Limited
NSE: POLYMEDINE205C01021·HealthcareSmallcap 250·www.polymedicure.com ↗·Mcap ₹17,504 Cr·Listed 2011
₹1,724.40▲ ₹8.40  (0.49%)
52W: ₹1,182 – ₹2,094 · Vol: 52.5K shares · Close 25 Sept
Set Alert

Quarterly results

consolidated · as filed with NSE · Q1 FY27 back to Q4 FY18
₹ croreQ1 FY27Q4 FY26Q3 FY26Q2 FY26Q1 FY26Q4 FY25Q3 FY25Q2 FY25Q1 FY25Q4 FY24Q3 FY24Q2 FY24Q1 FY24Q4 FY23Q3 FY23Q2 FY23Q4 FY22Q3 FY22Q2 FY22Q1 FY22Q4 FY21Q3 FY21Q2 FY21Q1 FY21Q4 FY20Q3 FY20Q2 FY20Q1 FY20Q4 FY19Q4 FY18
Revenue from operations5255354944444034414244203853783403373213072852752582302232122132042001701711801741621600
Other income33.417.826.333.941.724.321.826.116.91516.614.113.18.514.48.78.27.112.310.36.753.23.55.2454.24.70
Total expenses4434694173573233453353293043012692712522412332252171921861731691631571381491511441381360
EBITDA12511011111510611911511510496.690.284.287.283.27164.755.751.250.955.354.257.856.545.940.245.641.836.435.60
EBITDA margin23.8%20.7%22.5%25.8%26.3%27.1%27.0%27.5%27.0%25.5%26.6%25.0%27.2%27.1%24.9%23.5%21.6%22.2%22.8%26.1%25.4%28.4%28.3%26.9%23.4%25.2%24.1%22.5%22.2%–
Finance costs6.56.46332.23.33.33.23.13.52.22.52.34.80.51.4−0.60.23.2−1.84.82.82.88.15.41.63.21.90
Depreciation36.338.228.824.923.32121.520.919.616.216.21615.514.814.214.31413.613.512.912.512.611.4119.510.810.2109.30
Profit before tax11683.595.91211221211121179892.287.180.18374.666.458.748.545.349.449.550.145.545.535.527.833.43527.3290
Tax3220.226.829.929.9312830.524.424.122.818.820.316.316.815.812.611.312.212.61310.7119.56.28.67.17.97.50
Net profit85.36570.891.893.191.885.287.57468.46562.262.758.85043.536.234.538.237.638.835.33526.722.72528.419.821.50
Net margin16.2%12.2%14.3%20.7%23.1%20.8%20.1%20.8%19.2%18.1%19.1%18.4%19.5%19.2%17.6%15.8%14.0%15.0%17.1%17.7%18.2%17.3%17.5%15.7%13.2%13.9%16.3%12.3%13.4%–
EPS (₹)8.496.547.009.069.198.928.489.017.717.126.786.486.546.135.214.533.773.603.993.924.264.003.973.032.572.833.222.242.432.63
Net profit YoY−8.4%−29.2%−16.9%+5.0%+25.7%+34.3%+31.1%+40.6%+18.1%+16.2%+30.0%+43.0%–+62.6%+44.9%+13.8%−6.9%−2.3%+9.2%+40.7%+71.5%+41.1%+23.3%+34.9%+5.5%–––––

Annual results

financial years ending March · from the fourth-quarter filings
₹ croreFY26FY25FY24FY23FY22FY21FY20FY19FY18
Revenue from operations1,8751,6701,3761,1159237866876110
Other income12089.158.736.237.918.418.518.30
Total expenses1,5671,3121,0939167686285825300
EBITDA4424533582652132141641290
EBITDA margin23.6%27.1%26.0%23.8%23.1%27.3%23.9%21.2%–
Finance costs18.31211.38.84.38.518.311.80
Depreciation11682.663.957.25447.540.537.30
Profit before tax4224473422361931771241000
Tax1071148658.248.744.229.834.70
Net profit32133925817914713695.965.40
Net margin17.1%20.3%18.8%16.1%15.9%17.3%14.0%10.7%–
EPS (₹)31.7934.1326.9218.6915.2815.2510.867.411.83
Net profit YoY−5.3%+31.1%+44.1%+22.4%+7.8%+41.7%+46.6%––
EPS is as filed for each period and is not restated for later bonus issues or splits.

Cash flow

annual · ₹ crore
₹ croreFY26FY25FY24FY23FY22
Operating cash flow241241266191123
Investing cash flow−225−1,191−241−179−85.3
Financing cash flow20.2953−20.2−12.5−35.3
Capital expenditure308325277239156
Free cash flow (CFO − capex)−67.7−83.9−10.9−48.4−32.1

Net profit trend

annual, ₹ crore
FY21
₹136
FY22
₹147+8%
FY23
₹179+22%
FY24
₹258+44%
FY25
₹339+31%
FY26
₹321−5%

Result filings

as filed with NSE · PDF and XBRL
PeriodBasisFiledDocuments
Q1 FY27Consolidated7 Aug 2026PDF on NSE XBRL
Q1 FY27Standalone7 Aug 2026PDF on NSE XBRL
Q4 FY26Consolidated · audited25 May 2026PDF on NSE XBRL
Q4 FY26Standalone · audited25 May 2026PDF on NSE XBRL
Q3 FY26Consolidated5 Feb 2026PDF on NSE XBRL
Q3 FY26Standalone5 Feb 2026PDF on NSE XBRL
Q2 FY26Consolidated8 Nov 2025 PDF XBRL
Q2 FY26Standalone8 Nov 2025 PDF XBRL
Q1 FY26Consolidated8 Aug 2025 PDF XBRL
Q1 FY26Standalone8 Aug 2025 PDF XBRL

Annual reports

NSE archive
Key ratios
P/E (TTM)5Y avg 55.3×55.9×
P/B5Y avg 8.10×5.63×
ROEFY26, on average equity10.9%
Net margin17.1%
Debt / equity0.11×
Revenue CAGR (3Y)18.9%
Profit CAGR (3Y)21.4%
EPS (TTM)₹30.87
Market cap₹17,478 Cr
Computed from the filings and the last close. Market cap uses the latest share count from the balance sheet.
P/B vs history
5.63×
vs 8-point avg 8.10× (−31%)
3.89× low8.10× avg10.96× high
History points are balance-sheet dates (2022 → 2026), priced at the adjusted close on each date.
Balance sheet 31 Mar 2026
Total assets₹3,919 Cr+23%
Net worth₹3,106 Cr+12%
Total borrowings₹342 Cr+92%
Cash & bank balances₹51 Cr+489%
Investments₹740 Cr−30%
Inventories₹434 Cr+52%
Trade receivables₹531 Cr+52%
Trade payables₹123 Cr+42%
Change vs the same date a year earlier.
Shareholding 30 Jun 2026
%Jun 26Mar 26Dec 25Sept 25Jun 25Mar 25Dec 24Sept 24Aug 24Jun 24Mar 24Dec 23
Promoter62.4262.4262.4262.4262.4462.4462.4462.5662.5666.0353.1553.16
FII5.575.919.409.7711.4111.4612.3311.8711.109.9112.3814.10
DII16.0815.5913.8413.5411.7211.9611.6612.3312.489.357.225.45
of which MF9.618.848.148.047.34–––––––
Retail12.1812.6011.3011.2611.3711.0710.5510.1310.7011.3711.3411.38
Other public3.753.483.043.013.063.073.023.113.163.3415.9115.91
73,643 shareholders · NSE shareholding pattern filings.